Sanara MedTech (SMTI) Depreciation & Amortization (CF) (2010 - 2026)

Sanara MedTech (SMTI) has 16 years of Depreciation & Amortization (CF) data on file, last reported at $587252.0 in Q1 2026.

• Quarterly Depreciation & Amortization (CF) fell 47.77% year-over-year to $587252.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $3.4 million (down 31.03% YoY) and the FY2025 annual result came in at $3.9 million, down 19.85% from the prior year.
• Depreciation & Amortization (CF) slipped to $587252.0 in Q1 2026, from $668396.0 in the prior quarter.
• In the past five years, Depreciation & Amortization (CF) ranged from a high of $1.6 million in Q4 2024 to a low of $202747.0 in Q1 2022.
• A 5-year average of $911913.8 and a median of $997674.0 in 2023 frame the typical range for Depreciation & Amortization (CF).
• Annual changes were most pronounced in 2022 — Depreciation & Amortization (CF) soared 434.81% — and 2025, when it plunged 58.44%.
• Tracing SMTI's Depreciation & Amortization (CF) over 5 years: stood at $814316.0 in 2022, then surged by 34.44% to $1.1 million in 2023, then surged by 46.92% to $1.6 million in 2024, then sank by 58.44% to $668396.0 in 2025, then dropped by 12.14% to $587252.0 in 2026.
• The last three Depreciation & Amortization (CF) figures came in at $587252.0 (Q1 2026), $668396.0 (Q4 2025), and $1.0 million (Q3 2025), per Business Quant data.